Citius Oncology, Inc. (CTOR)
NASDAQ: CTOR · Real-Time Price · USD
1.970
+0.020 (1.03%)
At close: Jul 25, 2025, 4:00 PM
1.960
-0.010 (-0.51%)
After-hours: Jul 25, 2025, 7:59 PM EDT
Citius Oncology Market Cap
Citius Oncology has a market cap or net worth of $140.96 million as of July 25, 2025. Its market cap has increased by 86.50% in one year.
Market Cap
140.96M
Enterprise Value
144.76M
1-Year Change
86.50%
Ranking
Category
Stock Price
1.97
Market Cap Chart
Since December 8, 2022, Citius Oncology's market cap has increased from $90.21M to $140.96M, an increase of 56.25%. That is a compound annual growth rate of 18.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2025 | 139.53M | 69.57% |
| Dec 31, 2024 | 82.29M | -15.88% |
| Dec 29, 2023 | 97.81M | 7.68% |
| Dec 30, 2022 | 90.84M | 0.69% |
| Dec 8, 2022 | 90.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 706.97B |
| Johnson & Johnson | 401.86B |
| AbbVie | 333.14B |
| Novo Nordisk | 295.77B |
| UnitedHealth Group | 260.36B |
| Novartis AG | 224.80B |
| AstraZeneca | 216.82B |
| Abbott Laboratories | 214.57B |